| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 2 | -114K | 100% | $33.36 | -$3.81M |
| Net | -2 | -114K | -100% | -$3.81M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. | Director | $26.2M | Aug 10, 2021 | ||
| Pad Chivukula | Chief Scientific Officer & COO | $9.04M | -$2.2M | -19.6% | Oct 15, 2024 |
| Andy Sassine | Chief Financial Officer, Director | $7.06M | -$1.6M | -18.5% | Jun 12, 2024 |
| Peter C. Farrell | Director | $3.16M | Jun 14, 2024 | ||
| Magda Marquet | Director | $899K | Jun 14, 2024 | ||
| James F. Barlow | Director | $421K | Jun 14, 2024 | ||
| Edward W. Holmes | Director | $100K | Jun 14, 2024 | ||
| Jing L. Marantz | Director | $100K | Jun 14, 2024 | ||
| John Markels | Director | $100K | Jun 14, 2024 | ||
| Keith C. Kummerfeld | Senior Vice President of Finance (Principal Accounting Officer) | $17.8K | Dec 15, 2023 | ||
| Moncef Slaoui | Director | Jun 19, 2024 | |||
| Joseph E. Payne | President and CEO, Director | Dec 15, 2023 | |||
| Lance Kurata | Chief Legal Officer | Dec 15, 2023 | |||
| Karah Herdman Parschauer | Director | Jun 18, 2021 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|